Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Neoplasm Metastasis × pembrolizumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 79 OTHER 44 NIH 3 NETWORK 2 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Turcot syndrome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasm Metastasis 1 Lung Neoplasms 1

Interventions

enzalutamide 2 pembrolizumab 1 apalutamide 1 Fecal Microbiota Transplantation 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116775 2022-06-23

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Portland VA Medical Center

Phase 2 Unknown

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡